Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer.

Nanoscale

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.

Published: December 2022

Retraction of 'Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer' by Pengying Wu , , 2019, , 19520-19528, https://doi.org/10.1039/C9NR05791A.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d2nr90232jDOI Listing

Publication Analysis

Top Keywords

membrane based
8
based biomimetic
8
biomimetic nanocomposites
8
nanocomposites targeted
8
targeted therapy
8
therapy drug
8
drug resistant
8
resistant egfr-mutated
8
egfr-mutated lung
8
retraction cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!